We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
2326
DELISTED
Epizyme, Inc
EPZM
$2.04M ﹤0.01%
331,550
+55,974
+20% +$427K
CWH icon
2327
Camping World
CWH
$639M
$2.03M ﹤0.01%
177,285
+1,711
+1% +$30.3K
NHTC icon
2328
Natural Health Trends
NHTC
$14.7M
$2.03M ﹤0.01%
110,001
+68,184
+163% +$1.5M
NIC icon
2329
Nicolet Bankshares
NIC
$3.6B
$2.03M ﹤0.01%
41,571
-684
-2% -$35.5K
COWN
2330
DELISTED
Cowen Inc. Class A Common Stock
COWN
$2.03M ﹤0.01%
151,971
+3,754
+3% +$57.2K
CIO
2331
DELISTED
City Office REIT
CIO
$2.01M ﹤0.01%
196,041
+65,500
+50% +$733K
NOMD icon
2332
Nomad Foods
NOMD
$1.66B
$2.01M ﹤0.01%
119,991
+671
+0.6% +$12.8K
CIA icon
2333
Citizens
CIA
$239M
$2M ﹤0.01%
266,514
-2,607
-1% -$20.5K
IVC
2334
DELISTED
Invacare Corporation
IVC
$2M ﹤0.01%
465,004
+71,073
+18% +$628K
PKOH icon
2335
Park-Ohio Holdings
PKOH
$575M
$1.99M ﹤0.01%
64,712
-760
-1% -$26.5K
CASA
2336
DELISTED
Casa Systems, Inc. Common Stock
CASA
$1.99M ﹤0.01%
151,303
-8,349
-5% -$120K
WRD
2337
DELISTED
WildHorse Resource Development
WRD
$1.98M ﹤0.01%
140,137
-500
-0.4% -$9.85K
TRC icon
2338
Tejon Ranch
TRC
$457M
$1.97M ﹤0.01%
118,800
+7,869
+7% +$146K
INO icon
2339
Inovio Pharmaceuticals
INO
$55.7M
$1.97M ﹤0.01%
40,948
+470
+1% +$28.6K
SIGA icon
2340
SIGA Technologies
SIGA
$235M
$1.97M ﹤0.01%
248,839
-1,561
-0.6% -$8.93K
VRAY
2341
DELISTED
ViewRay, Inc.
VRAY
$1.95M ﹤0.01%
320,857
+2,070
+0.6% +$15.5K
WIN
2342
DELISTED
Windstream Holdings Inc
WIN
$1.95M ﹤0.01%
930,956
+197,478
+27% +$735K
IMAX icon
2343
IMAX
IMAX
$2.62B
$1.95M ﹤0.01%
103,399
+2,000
+2% +$40.8K
ATEX icon
2344
Anterix
ATEX
$1.81B
$1.94M ﹤0.01%
51,848
+477
+0.9% +$18.6K
RCKT icon
2345
Rocket Pharmaceuticals
RCKT
$340M
$1.93M ﹤0.01%
130,220
+6,020
+5% +$99.9K
SLDB icon
2346
Solid Biosciences
SLDB
$794M
$1.93M ﹤0.01%
4,800
-127
-3% -$59.7K
LDL
2347
DELISTED
Lydall, Inc.
LDL
$1.93M ﹤0.01%
94,733
-2,719
-3% -$74.2K
CNXN icon
2348
PC Connection
CNXN
$2.11B
$1.92M ﹤0.01%
64,418
+447
+0.7% +$14.3K
VECO icon
2349
Veeco
VECO
$3.05B
$1.92M ﹤0.01%
258,447
+15,231
+6% +$130K
EVRI
2350
DELISTED
Everi Holdings
EVRI
$1.91M ﹤0.01%
370,806
-508
-0.1% -$3.46K

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.